EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Beyond the Score: Fixed-Budget Benchmarking of Virtual Screening Integration Strategies for Decision-Centric Drug Discovery

Elisabetta Grazia Tomarchio iD, Rocco Buccheri iD, Antonio Rescifina iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27167497 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Elisabetta Grazia Tomarchio und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Drug and Health Sciences, University of Catania, Viale A. Doria 6, 95125 Catania, Italy. Hauptthemen laut MEDLINE: Drug Discovery. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Health, Fondazione ICSC Centro Nazionale di Ricerca in High Performance Computing, Big Data e Quantum Computing, Italian Ministry of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Virtual screening (VS) workflows often combine structure- and ligand-based methods; however, their value depends on the number of compounds that can be tested. We benchmarked 20 fixed-budget strategies derived from molecular docking (GNINA CNN score), maximum common substructure (MCS) similarity, and a calibrated machine-learning (ML)-QSAR classifier across five pharmacologically diverse targets. Individual methods, best-rank and worst-rank fusion, mean-rank consensus, and sequential funnels were evaluated at 1%, 5%, and 10% library fractions, with every strategy selecting the same number of compounds. ML-QSAR was the strongest standalone method, recovering 47.6%, 81.6%, and 84.4% of actives at the three cutoffs. At the 1% budget, ML-QSAR achieved the highest mean hit recovery (47.6% recall; 99.2% precision). At 5% and 10%, best-rank fusion of QSAR and MCS produced the highest mean recall (83.2% and 86.4%). Among the sequential workflows, QSAR → MCS achieved the highest 1% hit recovery (45.2 ± 3.3% recall), whereas docking-first funnels consistently underperformed under the default, non-optimized conditions evaluated in this study. Target-level results showed substantial variability in MCS-containing workflows and limited benefits from adding docking without target-specific optimization. Under matched assay budgets, a validated ligand-based predictor or a simple two-method rank-fusion scheme provided the highest observed mean hit recovery without requiring elaborate integration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug DiscoveryMolecular Docking SimulationQuantitative Structure-Activity RelationshipMachine LearningLigandsBenchmarking

Stichwörter der Autor:innen

QSARcomputer-aided drug discoveryfixed-budget benchmarkinghit recoverymachine learningmolecular dockingstructural similarityvirtual screening

Substanzen

Ligands

Autor:innen und Institutionen

  • Department of Drug and Health Sciences, University of Catania, Viale A. Doria 6, 95125 Catania, Italy.
  • Department of Biomedical and Biotechnological Sciences, University of Catania, Via Santa Sofia 97, 95123 Catania, Italy.

ORCID-Profile: Elisabetta Grazia Tomarchio, Rocco Buccheri, Antonio Rescifina

Förderung

  • Ministry of Health
  • Fondazione ICSC Centro Nazionale di Ricerca in High Performance Computing, Big Data e Quantum Computing
  • Italian Ministry of Health

Zitieren

APA

Tomarchio, E. G., Buccheri, R., & Rescifina, A. (2026). Beyond the Score: Fixed-Budget Benchmarking of Virtual Screening Integration Strategies for Decision-Centric Drug Discovery. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27167497

Vancouver

Tomarchio EG, Buccheri R, Rescifina A. Beyond the Score: Fixed-Budget Benchmarking of Virtual Screening Integration Strategies for Decision-Centric Drug Discovery. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27167497

BibTeX
@article{Tomarchio2026,
  author = {Tomarchio, Elisabetta Grazia and Buccheri, Rocco and Rescifina, Antonio},
  title = {Beyond the Score: Fixed-Budget Benchmarking of Virtual Screening Integration Strategies for Decision-Centric Drug Discovery},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27167497}
}
Kostenlos starten →